{
    "ticker": "PACB",
    "name": "Pacific Biosciences of California, Inc.",
    "description": "Pacific Biosciences of California, Inc. is a biotechnology company focused on providing innovative solutions for genetic analysis. Founded in 2004, PacBio is a leader in the development of high-quality, long-read sequencing technology that enables researchers to address some of the most complex questions in biology and medicine. The company's flagship product, the Sequel System, utilizes single-molecule, real-time (SMRT) sequencing technology to deliver accurate and comprehensive genomic data. This technology is revolutionizing genomics by enabling the study of large and complex genomes, including those of plants, animals, and humans. PacBio's systems are used in a variety of applications, including whole-genome sequencing, transcriptome analysis, and epigenomics, making it an essential tool for researchers in academia, government, and industry. The company's mission is to empower researchers to unlock the potential of genomics by providing them with the tools necessary to achieve unprecedented insights into biological systems. As the demand for genomic data continues to grow, PacBio is committed to advancing its technology and expanding its applications in personalized medicine, agriculture, and environmental sciences.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "Menlo Park, California, USA",
    "founded": "2004",
    "website": "https://www.pacb.com",
    "ceo": "Christian Henry",
    "social_media": {
        "twitter": "https://twitter.com/PacBio",
        "linkedin": "https://www.linkedin.com/company/pacific-biosciences/"
    },
    "investor_relations": "https://investors.pacb.com",
    "key_executives": [
        {
            "name": "Christian Henry",
            "position": "CEO"
        },
        {
            "name": "J. Andrew (Andy) Whitford",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Sequencing Systems",
            "products": [
                "Sequel II System",
                "Sequel System"
            ]
        },
        {
            "category": "Software",
            "products": [
                "SMRT Link",
                "Bioinformatics Software"
            ]
        }
    ],
    "seo": {
        "meta_title": "Pacific Biosciences | Innovative Genomic Solutions",
        "meta_description": "Explore Pacific Biosciences, a leader in genomic analysis and SMRT sequencing technology. Discover innovative products that advance research in biology and medicine.",
        "keywords": [
            "Pacific Biosciences",
            "Genomics",
            "Sequencing Technology",
            "Biotechnology",
            "SMRT Sequencing"
        ]
    },
    "faq": [
        {
            "question": "What technology does Pacific Biosciences use?",
            "answer": "Pacific Biosciences uses single-molecule, real-time (SMRT) sequencing technology."
        },
        {
            "question": "Who is the CEO of Pacific Biosciences?",
            "answer": "Christian Henry is the CEO of Pacific Biosciences."
        },
        {
            "question": "Where is Pacific Biosciences headquartered?",
            "answer": "Pacific Biosciences is headquartered in Menlo Park, California, USA."
        },
        {
            "question": "What are the main products of Pacific Biosciences?",
            "answer": "The main products include the Sequel II System and various bioinformatics software solutions."
        },
        {
            "question": "When was Pacific Biosciences founded?",
            "answer": "Pacific Biosciences was founded in 2004."
        }
    ],
    "competitors": [
        "ILMN",
        "GRMN",
        "NDAQ"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "CRSP"
    ]
}